CADL vs ENTA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CADL Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Candel Therapeutics, Inc. Common Stock (CADL) driven by superior Valuation, Growth & Margin, Momentum & Technical while ENTA counters with relative strength in Options & Structure. Fundamentally, CADL trades at 43.5x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ENTA at 44.0x Forward P/E and -90.0% operating margin (-21.6% YoY). In options structure, CADL sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro) against ENTA sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CADL Revenue | ENTA Revenue | CADL Op. Margin | ENTA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $210M | N/A | 42.7% | ENTA |
| FY2019 | N/A | $210M | N/A | 17.9% | ENTA |
| FY2020 | $0M | $120M | -11048.0% | -34.0% | ENTA |
| FY2021 | $0M | $100M | -20580.8% | -112.9% | ENTA |
| FY2022 | $0M | $90M | -27777.6% | -143.7% | ENTA |
| FY2023 | N/A | $80M | N/A | -173.2% | ENTA |
| FY2024 | N/A | $70M | N/A | -179.9% | ENTA |
| FY2025 | N/A | $70M | N/A | -130.7% | ENTA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CADL | ENTA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $642.0M | $326.2M | Larger Scale | CADL |
| Trailing P/E Ratio Valuation | 43.5x | 44.0x | Lower Multiple | CADL |
| Forward P/E Ratio Valuation | 43.5x | 44.0x | Lower Multiple | CADL |
| Revenue Growth (YoY) Growth | +0.0% | -21.6% | Higher Growth | CADL |
| Operating Margin (TTM) Profitability | 0.0% | -90.0% | Higher Margin | CADL |
| Net Profit Margin Profitability | 0.0% | -96.9% | Higher Margin | CADL |
| Return on Equity (ROE) Capital Efficiency | -93.7% | -70.1% | Higher ROE | ENTA |
| 52-Week Range Position Momentum | 18% ($4โ$14) | 10% ($10โ$17) | Stronger Trend | CADL |
| Beta / 30D Volatility Risk Regime | 2.12ฮฒ ยท 125% Vol | 0.89ฮฒ ยท 58% Vol | Lower Realized Risk | ENTA |
| Unified Institutional Score Composite Signal | 46.0 / 100 (HOLD) | 46.2 / 100 (HOLD) | Higher Composite | ENTA |